Welcome to LookChem.com Sign In|Join Free
  • or
Carbamic acid, [[(1,1-dimethylethoxy)carbonyl]oxy](phenylmethyl)-, 1,1-dimethylethyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

159879-41-1

Post Buying Request

159879-41-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

159879-41-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 159879-41-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,9,8,7 and 9 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 159879-41:
(8*1)+(7*5)+(6*9)+(5*8)+(4*7)+(3*9)+(2*4)+(1*1)=201
201 % 10 = 1
So 159879-41-1 is a valid CAS Registry Number.

159879-41-1Relevant academic research and scientific papers

The Use of N,O-bis(tert-Butoxycarbonyl)-hydroxylamine in the Synthesis of N-Hydroxylamines and Hydroxamic Acids

Staszak, Michael A.,Doecke, Christopher W.

, p. 6021 - 6024 (1994)

N,O-bis(tert-butoxycarbonyl)-hydroxylamine has been used in the synthesis of 5-lipoxygenase inhibitor LY280810.In addition, this reagent utilized to synthesize a number of other hydroxylamine and hydroxamic acid derivatives in high yields.

Discovery of a Highly Potent, Selective, and Metabolically Stable Inhibitor of Receptor-Interacting Protein 1 (RIP1) for the Treatment of Systemic Inflammatory Response Syndrome

Ren, Yan,Su, Yaning,Sun, Liming,He, Sudan,Meng, Lingjun,Liao, Daohong,Liu, Xiao,Ma, Yongfen,Liu, Chunyan,Li, Sisi,Ruan, Hanying,Lei, Xiaoguang,Wang, Xiaodong,Zhang, Zhiyuan

, p. 972 - 986 (2017/02/19)

On the basis of its essential role in driving inflammation and disease pathology, cell necrosis has gradually been verified as a promising therapeutic target for treating atherosclerosis, systemic inflammatory response syndrome (SIRS), and ischemia injury, among other diseases. Most necrosis inhibitors targeting receptor-interacting protein 1 (RIP1) still require further optimization because of weak potency or poor metabolic stability. We conducted a phenotypic screen and identified a micromolar hit with novel amide structure. Medicinal chemistry efforts yielded a highly potent, selective, and metabolically stable drug candidate, compound 56 (RIPA-56). Biochemical studies and molecular docking revealed that RIP1 is the direct target of this new series of type III kinase inhibitors. In the SIRS mice disease model, 56 efficiently reduced tumor necrosis factor alpha (TNFα)-induced mortality and multiorgan damage. Compared to known RIP1 inhibitors, 56 is potent in both human and murine cells, is much more stable in vivo, and is efficacious in animal model studies.

A survey of suitable protecting groups for the synthesis of hydroxylamines by Mitsunobu reactions

Knight, David W.,Leese, Mathew P.

, p. 2593 - 2595 (2007/10/03)

A variety of protecting groups, commonly associated with peptide synthesis, are suitable for the N,O-protection of hydroxylamine; the resulting reagents are all suitable for N-alkylhydroxylamine synthesis using the Mitsunobu method.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 159879-41-1